ATE173405T1 - Arzneimittel auf basis von hyaluronsäure - Google Patents

Arzneimittel auf basis von hyaluronsäure

Info

Publication number
ATE173405T1
ATE173405T1 AT92111469T AT92111469T ATE173405T1 AT E173405 T1 ATE173405 T1 AT E173405T1 AT 92111469 T AT92111469 T AT 92111469T AT 92111469 T AT92111469 T AT 92111469T AT E173405 T1 ATE173405 T1 AT E173405T1
Authority
AT
Austria
Prior art keywords
water
pharmacologically active
hyaluronic acid
soluble
products based
Prior art date
Application number
AT92111469T
Other languages
English (en)
Inventor
Yasutaka Igari
Minoru Yamada
Yasuaki Ogawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE173405T1 publication Critical patent/ATE173405T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92111469T 1991-07-10 1992-07-07 Arzneimittel auf basis von hyaluronsäure ATE173405T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17020591 1991-07-10

Publications (1)

Publication Number Publication Date
ATE173405T1 true ATE173405T1 (de) 1998-12-15

Family

ID=15900617

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92111469T ATE173405T1 (de) 1991-07-10 1992-07-07 Arzneimittel auf basis von hyaluronsäure

Country Status (4)

Country Link
EP (1) EP0522491B1 (de)
AT (1) ATE173405T1 (de)
CA (1) CA2073554C (de)
DE (1) DE69227607T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074512A (en) * 1991-06-27 2000-06-13 Applied Materials, Inc. Inductively coupled RF plasma reactor having an overhead solenoidal antenna and modular confinement magnet liners
SE9400036D0 (sv) * 1994-01-10 1994-01-10 Pharmacia Ab Low modecular weight hyaluronic acid
IL113010A0 (en) * 1994-03-31 1995-10-31 Pharmacia Ab Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
US5858477A (en) 1996-12-10 1999-01-12 Akashic Memories Corporation Method for producing recording media having protective overcoats of highly tetrahedral amorphous carbon
SE9904121D0 (sv) 1999-11-15 1999-11-15 Gustaf Jederstroem Hydrophobe biomolecular structure
JP2002003398A (ja) * 2000-04-17 2002-01-09 Ltt Institute Co Ltd 徐放製剤、その製造法及びワクチン
DE10064219B9 (de) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease

Also Published As

Publication number Publication date
CA2073554C (en) 2003-06-10
DE69227607D1 (de) 1998-12-24
DE69227607T2 (de) 1999-04-15
CA2073554A1 (en) 1993-01-11
EP0522491B1 (de) 1998-11-18
EP0522491A1 (de) 1993-01-13

Similar Documents

Publication Publication Date Title
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
ATE189772T1 (de) Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
DE69428040D1 (de) Orale darreichungsform
NO904378L (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
DE69230112D1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
ATE173405T1 (de) Arzneimittel auf basis von hyaluronsäure
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
ATE166233T1 (de) Verwendung von substanzen in partikelform
DK0559145T3 (da) Lægemiddel til truende abort
DE60028559D1 (de) Behandlung von multiplersklerose mit einer kombination von interferon und wachstumshormone
ES2182840T3 (es) Factor xiii para el tratamiento de heridas de la piel.
DE3781682D1 (de) Verbesserungen im gebrauch oder in bezug auf den gebrauch von egf.
DK15088D0 (da) Antibakterielt lyofiliseret praeparat
EP0582933A1 (de) Therapeutisches System zur parenteralen Verabreichung von hämatopoetischen Wachstumsfaktoren
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative
KR890001555A (ko) 요산 배설용 조성물
RU93052444A (ru) Лекарственный препарат бан
RU98109592A (ru) Применение белка s-100b в лекарственных средствах и лекарственные средства, содержащие белок s-100b
CA2159609A1 (en) Factor xiii for treatment of skin wounds
KR900701307A (ko) 항 비루스성 또는 항 박테리아성 화합물과 그 사용방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties